Philadelphia, PA (PRWEB) March 27, 2013
In response to the proliferation and complexity of clinical trials, MyClinicalTrialLocator.com will now offer consumers greater access to clinical trials around the world and help researchers access qualified participants. The development of the site has been supported and underwritten by the Biomedical Research and Education Foundation and the Bruce and Marsha Moskowitz Foundation.
The website, which is updated in real time 24 hours a day, addresses the needs of patients and physicians seeking up-to-the-minute information on clinical trials. Features that distinguish MyClinicalTrialLocator.com from other existing sites include access to clinical trials in the United States and around the world; a mapping function that shows the exact location of clinical trials; and push notification for patients who are searching for clinical trials for specific diseases, conditions, or wellness studies. The site, which is formatted to run on mobile devices, will eventually incorporate a planned social network, mobile applications, and the ability for patients with rare diseases to find one another and a clinician or researcher of interest.
“As the number of clinical trials increases, consumers need an easy way to target trials that are close to their homes or preferred medical institution, while researchers face increasing competition in enrolling enough trial participants to generate meaningful data,” says Charles Rudin, MD, PhD, Associate Director of Clinical Research for the Cancer Center at Johns Hopkins University, which is working closely with MyClinicalTrialLocator.com along with leading academic medical centers throughout the country.
MyClinicalTrialLocator.com has early support from the scientific and medical community and uses publicly available information from http://www.clinicaltrials.gov, as well as information from academic medical centers to create an easier and more accessible website for patients, parents and caregivers.
To use MyClinicalTrialLocator.com, consumers input the name of a disease or condition, their location, and the number of miles they are willing to travel. Once the information is entered, a list of both open and closed clinical trials appears. By clicking each listing, consumers receive comprehensive information on each clinical trial, recruitment information, eligibility, and contact information. The site also offers precise geographic locations, so users can see each clinical trial on a map. Users who register on the site can also request “push notification” when there is an appropriate clinical trial available based on their searches.
The free site also offers researchers the ability to reach patients about enrolling in clinical trials. Going forward, it will offer social networking features, connecting users interested in similar topics with other consumers, medical sites, and researchers.
About The Biomedical Research and Education Foundation (BREF):
BREF is a 501C3 not-for-profit organization created in November 2003 to provide independent information about the biomedical products in use today. BREF was founded with the concern that patients and doctors do not receive impartial information on the latest biomedical technology – whether it is an implanted device, new surgical procedure or diagnostic tool. The organization works closely with teaching hospitals and universities and consults with top experts and doctors from collaborating institutions to educate the public on appropriate uses of new technology and medical devices. BREF supports novel biomedical research that helps the advancement of medicine and strengthens the ties between financial communities and medical research.
About the Bruce and Marsha Moskowitz Foundation:
The Bruce and Marsha Moskowitz Foundation supports innovative health care solutions for childhood obesity, offers information for patients and physicians on implantable medical devices, assists patients and physicians to find clinical trials worldwide, and provides innovative nutritional programs for cancer patients who are undergoing chemotherapy and radiation therapy.